Manufacturing and Supply, page-18

First 18 Last

Share
Profile

Follow
kippax

4,131 Posts.

73

21/12/18

22:57

Post #: 36941441
Share

Originally posted by TheGreatAuk: ↑

Going off the due diligence and subsequent up front payment to Arena Pharma for a phase III drug to treat PAH, SUD004 is looking a little redundant. Phosphodiesterase-5 (PDE-5) inhibitors have positive effects in PAH, but they do not provide a cure, and in many patients the disease will progress despite treatment¹.

Uncertainty increasing in china. It is unclear when this procurement program will be rolled out nationwide and how many generic drugs will eventually be covered. It is important to recognize that under the program, the only determining factor for a successful bid will be the price. Thus, as global pharmaceutical companies look to do business in China, the implementation of this program will undoubtedly impact strategies on how to commercialize drug products in China and how to best compete in a bidding war with a domestic Chinese drug manufacturer².

There are at least 3 generic brands of zolpidem in china, 17 in India and 35 in Japan³. So another one is probably not a big deal.

Malaria pre-referral is stopgap only with RAS doing the job.

3.5c sooner than later sounds good.

1 https://www.biospace.com/article/ar...united-therapeutics-for-a-phase-iii-pah-drug/
2 https://www.hlregulation.com/2018/1...nsolidate-generic-drug-industry-lower-prices/
3 https://www.drugs.com/international/zolpidem.html

Expand

Hi TGA
I am not sure that saying that RAS is doing the job is correct. It might be doing a job but how can you say it is doing the job. Let's see comparison figures when WHO eventually approves the use of ArTiMist.
I note that clearance rates have stalled.....hmmmmmmm!!!!

kippax

SUD Price at posting: 0.6¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

CXM

'Taking money from the market': Garbage giant cleans up as this week's Hot Stock tip

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

There are more pages in this discussion • 19 more messages in this thread...

First 18 Last

Add SUD (ASX) to my watchlist

Manufacturing and Supply, page-18

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

'Taking money from the market': Garbage giant cleans up as this week's Hot Stock tip

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up